3-deazaadenosine analogues inhibit the production of tumour necrosis factor-α in RAW264.7 cells stimulated with lipopolysaccharide

Immunology

Volumn 89, Issue 4, 1996, Pages 558-562

  Jeong, S Y ^a   Lee, J H ^a   Kim, H S ^a   Hong, S H ^a   Cheong, C H ^a   Kim, I K ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEAZAADENOSINE; 3 DEAZAARISTEROMYCIN; 3 DEAZANEPLANOCIN A; ADENOSINE DERIVATIVE; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL LINE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029857144     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-781.x     Document Type: Article

References (24)

1. VASSALLI P. (1992) The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10, 411.
2. TRACEY K.J., FONG Y., HESSE D.G. et al. (1987) Anti-cachectin/TNF monoclonal antobodies prevent septic shock during lethal bacteraemia. Nature 330, 662.
3. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 263, 5380.
4. HAN J., THOMPSON P. & BEUTLER B. (1990) Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 172, 391.
5. SAMPAIO E.P., SARNO E.N., GALILLY R., COHN Z.A. & KAPLAN G. (1991) Thalidomide selectively inhibits tumor necrosis factor α production by stimulated human monocytes. J Exp Med 173, 699.
6. ZIEGLER-HEITBROCK H.W.L., STERNSDORF T., LIESE J. et al. (1993) Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes. J Immunol 151, 6986.
7. CHIANG P.K., RICHARDS H.H. & CANTONI G.L. (1977) 5-Adenosyl-L-homocysteine hydrolase: Analogues of S-adenosyl-L-homocysteine as potential inhibitors. Mol Pharmacol 13, 939.
8. GLAZER R.I., HARTMAN K.D., KNODE M.C. et al. (1986) 3-Deazaneplanocin: A new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60. Biochem Biophys Res Commun 135, 688.
9. ENDRESEN P.C., EIDE T.J. & AARBAKKE J. (1993) Cell death initiated by 3-deazaadenosine in HL-60 cells is apoptosis and is partially inhibited by homocysteine. Biochem Pharmacol 46, 1893.
10. SUNG S.J. & SILVERSTEIN S.C. (1985) Inhibition of macrophage phagocytosis by methylation inhibitors. J Biol Chem 260, 546.
11. KIM I.-K., AKSAMIT R.R. & CANTONI G.L. (1982) Mechanism of the cytostatic activity of 3-deazaaristeromycin, an inhibitor of adenosyl-homocysteine hydrolase. J Biol Chem 257, 14726.
12. AKSAMIT R.R., FALK W. & CANTONI G.L. (1982) Inhibition of chemotaxis by S-3- deazaadenosylhomocysteine in a mouse macrophage cell line. J Biol Chem 257, 621.
13. SCHMIDT J.A., BOMFORD R., GAO X.-M. & RHODES J. (1990) 3-Deazaadenosine, an inhibitor of interleukin 1 production by human peripheral blood monocytes. Int J Immunopharmacol 12, 89.
14. WANG A.M., CREASEY A.A., LADNER M.B. et al. (1985) Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 228, 149.
15. CHOMCZYNSKI P. & SACCHI N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156.
16. BACKLUND P.S. JR, CAROTTI D. & CANTONI G.L. (1986) Effects of the S-adenosylhomocysteine hydrolase inhibitors 3-deazaadenosine and 3-deazaaristeromycin on RNA methylation and synthesis. Eur J Biochem 160, 245.
17. AKSAMIT R.R., BACKLUND P.S. JR & CANTONI G.L. (1983) Chemotaxis and the synthesis of specific proteins are inhibited by 3-deazaadenosine and other adenosine analogs in a mouse macrophage cell line. J Biol Chem 258, 20.
18. SHAKHOV A.N., COLLART M.A., VASSALLI P., NEDOSPASOV S.A. & JONGENEEL C.V. (1990) κB- type entancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J Exp Med 171, 35.
19. MEDZIHRADSKY J.L. (1984) Regulatory role for the immune complex in modulation of phagocytosis by 3-deazaadenosine. J Immunol 133, 943.
20. WOLOS J.A., FRONDORF K.A. & ESSER R.E. (1993) Immunosuppression mediated by an inhibitor of 5-adenosyl-L-homocysteine hydrolase. J Immunol 151, 526.
21. WOLBERG G., ZIMMERMAN T.P., DUNCAN G.S., SINGER K.H. & ELION G.B. (1978) Inhibition of lymphocyte-mediated cytolysis by adenosine analogs. Biochemical studies concerning mechanism of action. Biochem Pharmacol 27, 1487.
22. WOLBERG G., ZIMMERMAN T.P., HIEMSTRA K., WINSTON M. & CHU L.-C. (1975) Adenosine inhibition of lymphocyte-mediated cytolysis: Possible role of cyclic adenosine monophosphate. Science 187, 957.
23. ZIMMERMAN T.P., RIDEOUT J.L., WOLBERG G., DUNCAN G.S. & ELION G.B. (1976) 2-Fluoroadenosine 3′;5′-monophosphate. A metabolite of 2-fluoroadenosine in mouse cytotoxic lymphocytes. J Biol Chem 251, 6757.
24. IKEHARA M. & FUKUI T. (1974) Studies of nucleosides and nucleotides. L8. Deamination of adenosine analogs with calf intestine adenosine deaminase. Biochim Biophys Acta 338, 512.